Regulation of human immunodeficiency virus type 1 Env-mediated membrane fusion by viral protease activity

被引:140
作者
Murakami, T
Ablan, S
Freed, EO
Tanaka, Y
机构
[1] Univ Ryukyus, Dept Immunol, Grad Sch Med, Nishihara, Okinawa 9030215, Japan
[2] Univ Ryukyus, Dept Immunol, Fac Med, Nishihara, Okinawa 9030215, Japan
[3] NIAID, Mol Microbiol Lab, Bethesda, MD 20892 USA
关键词
D O I
10.1128/JVI.78.2.1026-1031.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We and others have presented evidence for a direct interaction between the matrix (MA) domain of the human immunodeficiency virus type 1 (HIV-1) Gag protein and the cytoplasmic tail of the transmembrane envelope (Env) glycoprotein gp41. In addition, it has been postulated that the MA domain of Gag undergoes a conformational change following Gag processing, and the cytoplasmic tail of gp41 has been shown to modulate Env-mediated membrane fusion activity. Together, these results raise the possibility that the interaction between the gp41 cytoplasmic tail and MA is regulated by protease (PR)-mediated Gag processing, perhaps affecting Env function. To examine whether Gag processing affects Env-mediated fusion, we compared the ability of wild-type (WT) HIV-1 Env and a mutant lacking the gp41 cytoplasmic tail to induce fusion in the context of an active (PR+) or inactive (PR-) viral PR. We observed that PR- virions bearing WT Env displayed defects in cell-cell fusion. Impaired fusion did not appear to be due to differences in the levels of virion associated Env, in CD4-dependent binding to target cells, or in the formation of the CD4-induced gp41 six-helix bundle. Interestingly, truncation of the gp41 cytoplasmic tail reversed the fusion defect. These results suggest that interactions between unprocessed Gag and the gp41 cytoplasmic tail suppress fusion.
引用
收藏
页码:1026 / 1031
页数:6
相关论文
共 60 条
[1]   PRODUCTION OF ACQUIRED IMMUNODEFICIENCY SYNDROME-ASSOCIATED RETROVIRUS IN HUMAN AND NONHUMAN CELLS TRANSFECTED WITH AN INFECTIOUS MOLECULAR CLONE [J].
ADACHI, A ;
GENDELMAN, HE ;
KOENIG, S ;
FOLKS, T ;
WILLEY, R ;
RABSON, A ;
MARTIN, MA .
JOURNAL OF VIROLOGY, 1986, 59 (02) :284-291
[2]   Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease [J].
Berger, EA ;
Murphy, PM ;
Farber, JM .
ANNUAL REVIEW OF IMMUNOLOGY, 1999, 17 :657-700
[3]   PRELIMINARY ANALYSIS OF REQUIREMENTS FOR FUSION FROM WITHIN AND FUSION FROM WITHOUT BY NEWCASTLE DISEASE VIRUS [J].
BRATT, MA ;
GALLAHER, WR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1969, 64 (02) :536-&
[4]   Structural organization of authentic, mature HIV-1 virions and cores [J].
Briggs, JAG ;
Wilk, T ;
Welker, R ;
Kräusslich, HG ;
Fuller, SD .
EMBO JOURNAL, 2003, 22 (07) :1707-1715
[5]   POSTASSEMBLY CLEAVAGE OF A RETROVIRAL GLYCOPROTEIN CYTOPLASMIC DOMAIN REMOVES A NECESSARY INCORPORATION SIGNAL AND ACTIVATES FUSION ACTIVITY [J].
BRODY, BA ;
RHEE, SS ;
HUNTER, E .
JOURNAL OF VIROLOGY, 1994, 68 (07) :4620-4627
[6]  
CAPUTO A, 1990, J ACQ IMMUN DEF SYND, V3, P372
[7]   Measles viruses with altered envelope protein cytoplasmic tails gain cell fusion competence [J].
Cathomen, T ;
Naim, HY ;
Cattaneo, R .
JOURNAL OF VIROLOGY, 1998, 72 (02) :1224-1234
[8]   A matrix-less measles virus is infectious and elicits extensive cell fusion: consequences for propagation in the brain [J].
Cathomen, T ;
Mrkic, B ;
Spehner, D ;
Drillien, R ;
Naef, R ;
Pavlovic, J ;
Aguzzi, A ;
Billeter, MA ;
Cattaneo, R .
EMBO JOURNAL, 1998, 17 (14) :3899-3908
[9]   HIV entry and its inhibition [J].
Chan, DC ;
Kim, PS .
CELL, 1998, 93 (05) :681-684
[10]   Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus [J].
Chertova, E ;
Bess, JW ;
Crise, BJ ;
Sowder, RC ;
Schaden, TM ;
Hilburn, JM ;
Hoxie, JA ;
Benveniste, RE ;
Lifson, JD ;
Henderson, LE ;
Arthur, LO .
JOURNAL OF VIROLOGY, 2002, 76 (11) :5315-5325